Osmitrol Injection 10% 10 % (Mannitol SOLUTION) 10 %

Osmitrol Injection 10% is a sterile solution containing mannitol, used for intravenous administration. It is commonly utilized for its osmotic properties to promote diuresis and reduce intracranial or intraocular pressure.

Strength

10 %

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Osmitrol Injection 10% is primarily used to reduce elevated intracranial or intraocular pressure. It works by drawing fluid out of tissues and into the bloodstream, promoting diuresis. This can be beneficial in conditions where fluid accumulation needs to be managed. What is Osmitrol Injection 10% used for? It is often employed in medical settings to alleviate pressure-related symptoms and support fluid balance.

Side Effects

Common effects of Osmitrol Injection 10% may include increased urine output and potential electrolyte imbalances. Some individuals might experience dehydration or changes in blood pressure. These effects are generally monitored by healthcare professionals during administration.

Precautions & Warnings

Osmitrol Injection 10% should be handled with care, ensuring proper sterile techniques are followed. It is important to monitor fluid and electrolyte levels during use. Individuals with certain medical conditions, such as heart or kidney issues, should be closely observed when using this solution.

Avoid Interactions

Osmitrol Injection 10% may interact with other medications that affect fluid balance or electrolyte levels. It is advisable to consult with a healthcare provider before combining it with other treatments. Alcohol and certain diuretics might also influence its effects.

Frequently Asked Questions

Osmitrol Injection 10% is used to reduce elevated intracranial or intraocular pressure by promoting diuresis.

Osmitrol Injection 10% is administered intravenously, typically in a controlled medical setting.

Common effects include increased urine output and potential electrolyte imbalances, which are usually monitored by healthcare professionals.

Individuals with certain heart or kidney conditions should use Osmitrol Injection 10% with caution and under medical supervision.

Yes, Osmitrol Injection 10% may interact with medications that affect fluid balance or electrolyte levels, so consultation with a healthcare provider is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.